Watchlist Price Alert

AcelRx Pharmaceuticals In... (ACRX)

NASDAQ: ACRX · Real-Time Price · USD

0.86

0.06 (7.50%)

At close: Jan 09, 2024, 9:00 PM

AcelRx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-18.4M	47.76M	-35.1M	-40.38M	-53.24M	-47.15M	-51.51M	-43.16M
Depreciation & Amortization	311K	1.65M	1.97M	1.85M	1.67M	575K	1.74M	2.05M
Stock-Based Compensation	1.73M	2.89M	4.61M	4.42M	5.06M	5.17M	4.29M	4.48M
Other Working Capital	-29K	-1.69M	-88K	-4.06M	-112K	-177K	-1.83M	2.4M
Other Non-Cash Items	-1.79M	-79.23M	-2.5M	-2.12M	-1.71M	10.55M	11.83M	10.25M
Deferred Income Tax	703K	n/a	810K	n/a	951K	-86K	176K	-750K
Change in Working Capital	-1.54M	-1.39M	203K	-2.29M	-3.91M	1.87M	3.7M	-2.27M
Operating Cash Flow	-17.49M	-28.33M	-30M	-38.51M	-51.18M	-29.07M	-29.77M	-29.39M
Capital Expenditures	-100K	-364K	-1.83M	-1.85M	-3.47M	-819K	-2.4M	-3.72M
Cash Acquisitions	n/a	-1.69M	n/a	-35.99M	33.09M	n/a	n/a	n/a
Purchase of Investments	-3.65M	-7.86M	-70.46M	-44.61M	-100.07M	-30.56M	-7.57M	-996K
Sales Maturities Of Investments	500K	46.36M	46.98M	80.61M	66.97M	20.5M	n/a	6.53M
Other Investing Acitivies	2.72M	-1.69M	-821K	35.99M	-33.09M	-10.06M	-7.57M	5.53M
Investing Cash Flow	-528K	36.45M	-26.12M	34.14M	-36.56M	-10.88M	-9.97M	1.81M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-315K	-249K	-86K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.47M	-507K	41.51M	16.96M	14.45M	75.03M	12.33M	-26K
Financial Cash Flow	3.47M	-507K	41.51M	16.96M	14.45M	75.03M	12.33M	-26K
Net Cash Flow	-14.55M	7.61M	-14.61M	12.59M	-73.29M	35.07M	-27.41M	-27.61M
Free Cash Flow	-17.59M	-28.7M	-31.83M	-40.36M	-54.65M	-29.89M	-32.17M	-33.12M